Search for: "Regeneron"
Results 61 - 80
of 224
Sort by Relevance
|
Sort by Date
27 Feb 2021, 5:21 am
As discussed in Part 1, Regeneron (and Biogen) sufficiency requires a claim to be enabled across the entire scope of a claim (for features relating to the essence of the invention). [read post]
21 Feb 2021, 9:59 pm
The case arose when Amgen sued Sanofi and Regeneron over sales of Praluent® (alirocumab), which allegedly competes with Amgen's Repatha™... [read post]
18 Feb 2021, 10:24 am
The public information about manufacturing Regeneron’s and Eli Lilly’s cocktails is limited. [read post]
16 Feb 2021, 7:57 pm
Sanofi and Regeneron (Fed. [read post]
14 Feb 2021, 6:06 am
I am in love - in love with Sundays and catching up on some IP news...Feeling the love...PATENTS The High Court decision in Illumina v MGI is the first to take an in depth look at the thorny issue of sufficiency since last year's Supreme Court decision in Regeneron v Kymab. [read post]
5 Feb 2021, 4:58 am
Sufficiency: Regeneron and chocolate teapotsIn Regeneron, the Supreme Court had to decide whether a patent claiming a transgenic mouse product was enabled across the entire scope of the claimed invention. [read post]
29 Jan 2021, 2:00 pm
In the 571-patient trial a 6mg dose of the single-chain antibody fragment was non-inferior to 2mg of Regeneron/Bayer's Eylea in terms of baseline changes in best corrected visual acuity. [read post]
29 Jan 2021, 10:26 am
Regeneron’s antibody combination treatment had similar results. [read post]
29 Jan 2021, 7:20 am
Insufficiency: Regenerating Regeneron Birss J gave extensive consideration to a challenge of insufficiency made by the Defendants in reliance on Regeneron v Kymab [2020] UKSC 27. [read post]
27 Jan 2021, 2:10 pm
For example, recently, national news reports revealed that health officials inadvertently gave 42 people the Regeneron IV Covid treatment, instead of the Covid-19 immunization. [read post]
20 Jan 2021, 6:42 pm
It is reported that two versions of vial and carton labels for the Regeneron antibody exist, but neither includes the name of the specific antibody or has a functioning barcode. [read post]
14 Jan 2021, 9:15 am
At the PTAB, parties filed just 16 petitions—three post grant reviews (PGRs) (including a Regeneron filing) and 13 inter partes reviews (IPRs), which, if memory serves, is the lowest of the past 12 months. [read post]
14 Jan 2021, 9:15 am
At the PTAB, parties filed just 16 petitions—three post grant reviews (PGRs) (including a Regeneron filing) and 13 inter partes reviews (IPRs), which, if memory serves, is the lowest of the past 12 months. [read post]
7 Jan 2021, 1:32 pm
From the outset, this launch of Beovu in the US was a bit rocky for Novartis, as seen by the following excerpt from this October 8, 2019, Fierce Pharma piece, "Novartis takes on Regeneron, Roche blockbusters with Beovu approval": The drug won approval for 8- and 12-week dosing intervals after a three-month loading phase of monthly injections. [read post]
5 Jan 2021, 12:28 pm
The Boston US Attorney’s office has collected nearly a billion dollars pursuing cases with a similar theory against many giants in the industry including Pfizer, United Therapeutics, Amgen, Astellas, Alexion, Actelion, Jazz, and Sanofi-Aventis and is currently pursuing a similar case against Regeneron. [read post]
28 Dec 2020, 3:01 pm
Four highlights from this week: DOJ Accuses Zoom Exec of Acting on Behalf of Chinese Government; CISA Releases CISA Insights and Creates Webpage on Ongoing APT Cyber Activity; ACLU Sues For Info On FBI’s Encryption Breaking Capabilities; New tools to fight gift card scams; Officials shut down fake Moderna, Regeneron websites that allegedly stole users’ info for cyberattacks. [read post]
27 Dec 2020, 7:34 pm
Four highlights from this week: DOJ Accuses Zoom Exec of Acting on Behalf of Chinese Government; CISA Releases CISA Insights and Creates Webpage on Ongoing APT Cyber Activity; ACLU Sues For Info On FBI's Encryption Breaking Capabilities; New tools to fight gift card scams; Officials shut down fake Moderna, Regeneron websites that allegedly stole users' info for cyberattacks. [read post]
23 Dec 2020, 5:31 am
The main course – Supreme Court cases (7) Modified Mouse Surprise In Regeneron Pharmaceuticals v Kymab [2020] UKSC 27, the UK Supreme Court reviewed the principle of general application in relation to Regeneron’s patents for the creation of a range of types of transgenic mice that produce chimeric antibodies. [read post]
14 Dec 2020, 10:31 pm
Jane LambertPatents Court (Mr Justice Birss) Regeneron Pharmaceuticals, Inc. and another v Rinat Neuroscience Corp. [2020] EWHC 3359 (Pat) (7 Dec 2020)Interest rei publicae ut sit finis litium. [read post]
29 Oct 2020, 10:56 am
In Regeneron Pharmaceuticals Inc v. [read post]
